Bleeding Risk in Post-bariatric Abdominoplasties: A Large Cohort Study

减重手术后腹部整形术的出血风险:一项大型队列研究

阅读:1

Abstract

BACKGROUND: Post-bariatric abdominoplasty is a standard procedure to improve body contour and quality of life following massive weight loss. However, perioperative bleeding remains a concern, particularly in the context of thromboprophylaxis and pre-existing comorbidities. This study investigates the risk factors for bleeding, including hypertension and bariatric surgery type, in patients undergoing abdominoplasty post-bariatric surgery. METHODS: Patient data were retrospectively collected from a tertiary centre in Italy. Patient demographics, comorbidities, bariatric surgery type, and thromboprophylaxis use were analysed. Univariable and multivariable regression analyses identified significant predictors of bleeding. Risk ratios (RR) were calculated for bleeding outcomes based on bariatric surgery type and patient variables. RESULTS: A total of 201 patients who underwent abdominoplasty following bariatric surgery were included in the analysis. The cohort had a median age of 44 years, with 71% female (142/201). Hypertension was significantly associated with bleeding risk (β = 0.1, p = 0.047; RR = 2.5, 95% CI: 1.02-6.01, p = 0.045). Among bariatric procedures, gastric banding conferred the highest bleeding risk compared to mini-gastric bypass (RR = 6.8, 95% CI: 2.09-21.8, p = 0.001). Sleeve gastrectomy also showed a higher bleeding risk than mini-gastric bypass (RR = 3.3, 95% CI: 1.24-8.5, p = 0.016). CONCLUSION: Hypertension emerged as an independent risk factor for bleeding in post-bariatric abdominoplasty, increasing risk by more than twofold. Additionally, bariatric surgery type influenced outcomes, with gastric banding and sleeve gastrectomy associated with higher bleeding risk compared to mini-gastric bypass. These findings highlight the importance of preoperative optimisation and surgical planning to mitigate bleeding complications. LEVEL OF EVIDENCE V: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。